417 related articles for article (PubMed ID: 35714328)
21. Multiplexed evaluation of immunity against SARS-CoV-2 variants using surface enhanced fluorescence from a nanostructured plasmonic chip.
Hu R; Yang Y; Liu Y; Liao T; Liu Y; Tang J; Wang G; Wang G; Liang Y; Yuan J; Zhang B
J Nanobiotechnology; 2022 Dec; 20(1):533. PubMed ID: 36522786
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection.
Widyasari K; Jang J; Kang T; Kim S
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632098
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination.
Lim SY; Park S; Kim JY; Kim S; Jee Y; Kim SH
Clin Infect Dis; 2022 Dec; 75(12):2243-2246. PubMed ID: 35686300
[TBL] [Abstract][Full Text] [Related]
24. Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.
Gilboa M; Regev-Yochay G; Mandelboim M; Indenbaum V; Asraf K; Fluss R; Amit S; Mendelson E; Doolman R; Afek A; Freedman LS; Kreiss Y; Lustig Y
JAMA Netw Open; 2022 Sep; 5(9):e2231778. PubMed ID: 36107426
[TBL] [Abstract][Full Text] [Related]
25. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK
Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684
[TBL] [Abstract][Full Text] [Related]
26. Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine.
Chen LL; Chua GT; Lu L; Chan BP; Wong JS; Chow CC; Yu TC; Leung AS; Lam SY; Wong TW; Tsang HW; Wong IC; Chan KH; Yuen KY; Ip P; Kwan MY; To KK
Emerg Microbes Infect; 2022 Dec; 11(1):543-547. PubMed ID: 35084295
[TBL] [Abstract][Full Text] [Related]
27. Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Ahmed-Belkacem A; Redjoul R; Brillet R; Ahnou N; Leclerc M; López-Molina DS; Soulier A; Gourgeon A; Rodriguez C; Maury S; Pawlotsky JM; Fourati S
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146735
[TBL] [Abstract][Full Text] [Related]
28. Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.
Bednarski E; Del Rio Estrada PM; DaSilva J; Boukadida C; Zhang F; Luna-Villalobos YA; Rodríguez-Rangel X; Pitén-Isidro E; Luna-García E; Díaz Rivera D; López-Sánchez DM; Tapia-Trejo D; Soto-Nava M; Astorga-Castañeda M; Martínez-Moreno JO; Urbina-Granados GS; Jiménez-Jacinto JA; Serna Alvarado FJ; Enriquez-López YE; López-Arellano O; Reyes-Teran G; Bieniasz PD; Avila-Rios S; Hatziioannou T
mBio; 2022 Aug; 13(4):e0084022. PubMed ID: 35735743
[TBL] [Abstract][Full Text] [Related]
29. Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination.
Das S; Singh J; Shaman H; Singh B; Anantharaj A; Sharanabasava P; Pandey R; Lodha R; Pandey AK; Medigeshi GR
Nat Commun; 2022 Jun; 13(1):3451. PubMed ID: 35705548
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
[TBL] [Abstract][Full Text] [Related]
31. Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant.
Yu X; Qi X; Cao Y; Li P; Lu L; Wang P; Feng Y; Yang J; Wei H; Guo L; Sun M; Liu Q; Lv J; Feng Y
Emerg Microbes Infect; 2022 Dec; 11(1):749-752. PubMed ID: 35176972
[TBL] [Abstract][Full Text] [Related]
32. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A; Kotaki R; Yamada S; Kuroda Y; Yamamoto T; Ishijima K; Park ES; Inoue Y; Kaku Y; Tobiume M; Iwata-Yoshikawa N; Shiwa-Sudo N; Tokunaga K; Ozono S; Hemmi T; Ueno A; Kishida N; Watanabe S; Nojima K; Seki Y; Mizukami T; Hasegawa H; Ebihara H; Maeda K; Fukushi S; Takahashi Y; Suzuki T
Med; 2022 Apr; 3(4):249-261.e4. PubMed ID: 35261995
[TBL] [Abstract][Full Text] [Related]
33. Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies.
Schulz SR; Hoffmann M; Roth E; Pracht K; Burnett DL; Mazigi O; Schuh W; Manger B; Mielenz D; Goodnow CC; Christ D; Pöhlmann S; Jäck HM
Eur J Immunol; 2022 Jun; 52(6):970-977. PubMed ID: 35253229
[TBL] [Abstract][Full Text] [Related]
34. [Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases].
Zhang PP; Guo YT; Chu YQ; Ji QI; Lian Y; Li W; Yao LN
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):736-741. PubMed ID: 35894186
[TBL] [Abstract][Full Text] [Related]
35. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
36. Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections.
Singh G; Abbad A; Tcheou J; Mendu DR; Firpo-Betancourt A; Gleason C; Srivastava K; Cordon-Cardo C; Simon V; Krammer F; Carreño JM
J Infect Dis; 2023 Aug; 228(5):564-575. PubMed ID: 37104046
[TBL] [Abstract][Full Text] [Related]
37. The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.
Farias JP; Pinheiro JR; Andreata-Santos R; Fogaça MMC; da Silva Brito RD; da Cruz EF; de Castro-Amarante MF; Pereira SS; Dos Santos Almeida S; Moreira LM; da Conceição Simões R; Luiz WB; Birbrair A; Belmok A; Ribeiro BM; Maricato JT; Braconi CT; de Souza Ferreira LC; Janini LMR; Amorim JH
J Med Virol; 2023 Feb; 95(2):e28481. PubMed ID: 36609686
[TBL] [Abstract][Full Text] [Related]
38. Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia.
Zapata-Cardona MI; Flórez-Álvarez L; Lopera TJ; Chvatal-Medina M; Zapata-Builes W; Diaz FJ; Aguilar-Jimenez W; Taborda N; Hernandez JC; Rugeles MT
Front Immunol; 2022; 13():1102384. PubMed ID: 36618393
[TBL] [Abstract][Full Text] [Related]
39. Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
Wang B; Xu J; Wu S; Zhang Z; Zhao Z; Zhang J; Fu L; Zai X; Wang Y; Zhang G; Chen Z; Chen Y; Sun H; Song X; Zhang J; Zhu L; Hou L; Chen W
Signal Transduct Target Ther; 2022 Jul; 7(1):257. PubMed ID: 35906201
[TBL] [Abstract][Full Text] [Related]
40. High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
Guirakhoo F; Wang S; Wang CY; Kuo HK; Peng WJ; Liu H; Wang L; Johnson M; Hunt A; Hu MM; Monath TP; Rumyantsev A; Goldblatt D
J Infect Dis; 2022 Oct; 226(8):1401-1406. PubMed ID: 35723969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
